ETF · holdings as filed 2026-05-31

What's inside FMED?

Fidelity Disruptive Medicine ETF
Holdings
69
positions in the fund
Top 10
36%
of fund assets
Expense ratio
0.50%
net, per year
Fund size
$41M
total net assets
Sectors
Top holdings — Health Care
Your 10 largest positions in this sector
1
L
LFSTLIFESTANCE HEALTH GROUP INC
3.87%
2
D
DHRDANAHER CORP
3.10%
3
T
TXG10X GENOMICS INC-CLASS A
2.82%
4
I
ISRGINTUITIVE SURGICAL INC
2.65%
5
C
COGTCOGENT BIOSCIENCES INC
2.59%
6
A
ALNYALNYLAM PHARMACEUTICALS INC
2.53%
7
A
ARGXARGENX SE - ADR
2.53%
8
L
LEGNLEGEND BIOTECH CORP-ADR
2.08%
9
T
TECHBIO-TECHNE CORP
2.03%
10
A
ASNDASCENDIS PHARMA A/S
1.92%
Geography
Top holdings — United States
Your 10 largest positions in this country
1
L
LFSTLIFESTANCE HEALTH GROUP INC
3.87%
2
D
DHRDANAHER CORP
3.10%
3
T
TXG10X GENOMICS INC-CLASS A
2.82%
4
I
ISRGINTUITIVE SURGICAL INC
2.65%
5
C
COGTCOGENT BIOSCIENCES INC
2.59%
6
A
ALNYALNYLAM PHARMACEUTICALS INC
2.53%
7
L
LEGNLEGEND BIOTECH CORP-ADR
2.08%
8
U
UNHUNITEDHEALTH GROUP INC
2.04%
9
T
TECHBIO-TECHNE CORP
2.03%
10
E
EWEDWARDS LIFESCIENCES CORP
1.91%
Geography reflects each issuer's registered business address per SEC EDGAR filings where available, falling back to the exchange or listing where no SEC filing exists — not necessarily where a company's stock is primarily listed (e.g. TSMC is classified as Taiwan even though its ADR trades on the NYSE).
Hold FMED alongside other funds? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →
Data source: official SEC Form N-PORT filings (as of 2026-05-31); expense ratio from SEC prospectus (risk/return) filings. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.